Medical Statistics < Medicine < Mie

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000345 (2013)	J. J. Kim ; K. S. Na ; T. H. Kim ; D. H. Yoo	THU0466 Pilot Trial of Tocilizumab for Refractory Patients with Adult Onset Still’s Disease
000419 (2013)	R. Watanabe ; H. Okuno ; T. Ishii ; H. Harigae ; Y. Hirabayashi [Japon]	AB0330 Long-term administration of tocilizumab increases the structural remission rate year by year and continuously inhibits radiographic progression: 3 year results from michinoku tocilizumab study group
000524 (2013)	M. Yamamoto ; H. Takahashi ; Y. Naishiro ; T. Tabeya ; K. Ishigami ; Y. Shimizu ; H. Yajima ; M. Matsui ; C. Suzuki ; H. Yamamoto ; S. Honda ; T. Abe ; Y. Suzuki ; T. Himi ; K. Imai [Japon] ; Y. Shinomura	THU0398 Efficacy of rituximab and other immunosuppressants for IgG4-related disease
000552 (2013)	T. E. Markatseli ; P. Kosta [Grèce] ; I. Saougou ; P. V. Voulgari ; M. I. Argyropoulou [Grèce] ; A. A. Drosos	AB0579 Abatacept in rheumatoid arthritis: Clinical and imaging considerations
000556 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. Ishiguro	SAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
000567 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. Ishiguro	AB0338 Evaluation of tocilizumab treatment continuation rate stratified by time of start of administration
000572 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; T. Shioura ; N. Asai ; T. Kobayakawa ; K. Saito [Japon] ; N. Ishiguro	AB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry
000623 (2013)	Y. J. Kim ; B. S. Koo ; M.-W. So ; W. J. Seo ; Y.-G. Kim ; C.-K. Lee ; B. Yoo	AB0337 Blood b cell counts as predictor of early clinical response after rituximab in patients with rheumatoid arthritis
000657 (2013)	Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. Ishiguro	AB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy
000718 (2013)	E. Della Torre [Italie] ; S. Franchini [Italie] ; E. Baldissera [Italie] ; G. Cavalli ; E. P. Bozzolo [Italie] ; M. G. Sabbadini [Italie]	THU0386 Efficacy of long-term treatment with biologic agents in refractory adult onset still’s disease: A single centre experience on 16 patients
000804 (2013)	T. Takeuchi [Japon] ; Y. Kaneko [Japon] ; T. Atsumi ; Y. Tanaka ; M. Inoh ; H. Kobayashi [Japon] ; K. Amano ; M. Miyata ; Y. Murakawa ; T. Fujii ; A. Kawakami ; H. Yamanaka ; K. Yamamoto ; N. Miyasaka [Japon] ; T. Mimori	OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study)
000937 (2013)	Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. Ishiguro	AB0339 A retrospective study on rapidness of efficacy in abatacept terapy in patients with rheumatoid arthritis from japanese multicenter registry system
000939 (2013)	A. Ihata ; H. Hagiyama ; S. Nagaoka ; J. Obata ; K. Miyachi ; H. Yamada ; S. Hirohata ; N. Koido ; M. Yamasaki ; K. Miyagi ; S. Ohno [Japon] ; D. Kishimoto ; K. Takase ; M. Hama ; R. Yoshimi ; A. Ueda ; M. Takeno ; Y. Ishigatsubo	FRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48)
000992 (2013)	I. A. Choi ; J.-H. Kim [Corée du Sud] ; Y. M. Kim [Corée du Sud] ; K. H. Kim [Corée du Sud] ; H. W. Kim ; K. Shin ; E. Y. Lee ; E. B. Lee ; Y.-M. Lee [Corée du Sud] ; Y. W. Song	THU0058 Periodontal disease is associated with rheumatoid arthritis (RA) but its severity is not correlated with RA disease activity
000B78 (2013)	A. Nakashima ; Z. Takeshi ; K. Ogane ; K. Yamada ; M. Kawano ; A. Yachie [Japon]	FRI0102 The significance of serum iga in rheumatoid arthritis in the era of biologic therapy
000B87 (2013)	K. Ebina ; K. Shi ; T. Tomita ; Y. Kunugiza ; M. Hirao ; J. Hashimoto [Japon] ; H. Yoshikawa	SAT0495 Assessment of Plantar Pressure Distribution During Walking after Forefoot Surgery in Patients with Rheumatoid Arthritis
000C33 (2013)	S. Kaneshiro ; K. Ebina ; M. Hirao [Japon] ; J. Hashimoto [Japon] ; K. Shi ; H. Yoshikawa	FRI0054 IL-6 negatively regulates osteoblast differentiation through ERK pathway in vitro
000D58 (2013)	S. Saevarsdottir ; L. Stawiarz [Suède] ; C. Turesson [Suède] ; S. Linblad	SAT0133 Previous Biological Therapies Influence Drug Survival in Rheumatoid Arthritis Patients Starting Abatacept Treatment 2006-2012.
000D68 (2013)	L. Yang [Japon] ; S. Serada [Japon] ; M. Fujimoto [Japon] ; H. Murota ; Y. Kotobuki [Japon] ; S. Kitaba ; T. Naka [Japon] ; I. Katayama	OP0230 Periostin, a novel matricellular protein, is required for cutaneous sclerosis in a mouse model of scleroderma
000E83 (2012)	Makio Kusaoi [Japon] ; Ken Yamaji ; Go Murayama ; Misa Yasui ; Risa Yamada ; Ruka Hishinuma ; Takuya Nemoto ; Katsura Hohtatsu ; Michiaki Kageyama ; Toshio Kawamoto ; Kaoru Sugimoto ; Fumio Sekiya ; Takayuki Kon ; Michihiro Ogasawara ; Kazuo Kempe ; Hiroshi Tsuda [Japon] ; Yoshinari Takasaki	Gene Expression Analysis Using a High‐Resolution DNA Microarray of Peripheral Whole Blood Immediately Before and After Leukocytapheresis for Rheumatoid Arthritis
000F80 (2013)	Y. Takakuwa ; H. Yamada ; H. Ito ; S. Ooka ; Y. Yamasaki ; H. Nakano ; M. Hiida ; Y. Kurihara [Japon] ; S. Ozaki	THU0410 Characterisation of interstitial lung disease associated with adult still’s disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPaysInc.i -k "Medicine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPaysInc.i  \
                -Sk "Medicine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AffPaysInc.i
   |clé=    Medicine
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021